Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial nitroreductases (NTRs) are a family of flavin-containing enzymes that catalyze the reduction of nitroaromatic and nitroheterocyclic compounds using NAD(P)H as an electron donor. These enzymes are widely exploited in medicine, particularly in antimicrobial therapy and cancer gene therapy. In antimicrobial applications, bacterial NTRs activate prodrugs like nitrofurantoin, metronidazole, pretomanid, and delamanid into highly reactive cytotoxic intermediates that damage bacterial DNA and proteins, leading to cell death. In oncology, bacterial NTRs (such as E. coli NfsB) are utilized in gene-directed enzyme prodrug therapy (GDEPT) and antibody-directed enzyme prodrug therapy (ADEPT). In these strategies, the NTR gene is selectively delivered to tumor cells, which then express the enzyme and locally activate prodrugs like CB1954 into potent DNA cross-linking agents, minimizing systemic side effects. However, challenges remain, including potential off-target toxicity from the bystander effect and the development of resistance through bacterial mutations in NTR-encoding genes.
Bacterial nitroreductases catalyze the NAD(P)H-dependent reduction of nitroaromatic compounds and nitroimidazoles. This enzymatic reduction converts relatively non-toxic prodrugs into highly reactive, cytotoxic intermediates (such as nitroso, hydroxylamine, or amine derivatives) that cause DNA damage, DNA cross-linking, and cell death.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial nitroreductase (NTR).